DISPERGIERBARE BOSERTAN-TABLETTE

European patent · EP1883397 · Deleted

Register entry

Publication number
EP1883397
Application number
EP06744942
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
May 15, 2006
Published
Feb 6, 2008
Granted
Dec 16, 2009
Deleted
May 15, 2026
Reason
Maximum term reached
IPC classes
A61K 9/20 (2006.01)
A61K 31/513 (2006.01)
Priority
WO PCT/EP2005/005367 17.05.2005
PCT application
PCT/IB2006/051519 15.05.2006
PCT publication
WO2006/123285 23.11.2006
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 15, 2026

    Maximum term reached

    Status of protective title
    Active → Cancelled
    Cancellation date
    15.05.2026
    Cause for cancellation
    Expiry of maximum term of protection

    Published in Swissreg on 15.05.2026

  2. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  3. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  4. Jun 1, 2023

    Change

    Published in Swissreg on 01.06.2023

  5. Dec 16, 2009

    Granted

    Published in Swissreg on 16.12.2009

Parties

Holder

Actelion Pharmaceuticals Ltd

Actelion Pharmaceuticals Ltd.

Gewerbestrasse 16, 4123 Allschwil

Inventor

HOLMAN, Lovelace

CH-4144 Arlesheim

TRENKTROG, Timm

CH-4102 Binningen

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.